Literature DB >> 8809662

Normal ageing in adults with Down's syndrome: a longitudinal study.

D A Devenny1, W P Silverman, A L Hill, E Jenkins, E A Sersen, K E Wisniewski.   

Abstract

The ubiquitous presence of the neuropathology of Alzheimer disease (AD) in individuals with Down's syndrome (DS) over 40 years of age suggests that this group of people will exhibit a high prevalence of dementia of the Alzheimer type (DAT) as they age. The present study indicates that there is a clear discrepancy between the presumed presence of AD neuropathology and the clinical expression of DAT among older people with DS. In the first 6 years of a longitudinal study, the present authors compared 91 adults (31-63 years of age) with DS and mild or moderate mental retardation to 64 adults (31-76 years of age) with other forms of mental retardation (MR) on yearly measures of mental status, short- and long-term memory, speeded psychomotor function, and visuospatial organization. The results indicated that, over repeated testing on the verbal long-term memory test, younger participants with DS showed small increases in their scores, while older participants with DS showed very slight decreases. Overall performance scores on this test and a speeded psychomotor task were poorer for both diagnostic groups in individuals aged 50 years and older. The magnitude and type of these selective changes in performance were consistent with performance profiles observed in older healthy adults without mental retardation on tests measuring similar cognitive functions. Only four out of the 91 people with DS in the present sample showed changes in functioning that have led to a diagnosis of possible DAT, and in these individuals, alternative causes of performance declines were concurrently present (e.g. thyroid dysfunction). These findings indicate that some age-associated changes in functioning are related to "normal' but probably precocious ageing among adults with DS. Furthermore, these findings suggest that adults with DS and mild or moderate mental retardation may be at lower risk for dementia during their fourth and fifth decades of life than previous studies have suggested.

Entities:  

Mesh:

Year:  1996        PMID: 8809662

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  18 in total

1.  Working memory in the aged Ts65Dn mouse, a model for Down syndrome.

Authors:  Katharine N Whitney; Galen R Wenger
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

2.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

Review 3.  Neuropsychiatric and behavioral aspects of trisomy 21.

Authors:  Jeannie Visootsak; Stephanie Sherman
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

4.  Stability and change in health, functional abilities, and behavior problems among adults with and without Down syndrome.

Authors:  Anna J Esbensen; Marsha Mailick Seltzer; Marty Wyngaarden Krauss
Journal:  Am J Ment Retard       Date:  2008-07

5.  Growth and Decline in Language and Phonological Memory Over Two Years Among Adolescents With Down Syndrome.

Authors:  Frances A Conners; Andrew S Tungate; Leonard Abbeduto; Edward C Merrill; Gayle G Faught
Journal:  Am J Intellect Dev Disabil       Date:  2018-03

6.  Long-term impact of parental well-being on adult outcomes and dementia status in individuals with Down syndrome.

Authors:  Anna J Esbensen; Marsha R Mailick; Wayne Silverman
Journal:  Am J Intellect Dev Disabil       Date:  2013-07

7.  Differentiating Aging Among Adults With Down Syndrome and Comorbid Dementia or Psychopathology.

Authors:  Anna J Esbensen; Emily Boshkoff Johnson; Joseph L Amaral; Christine M Tan; Ryan Macks
Journal:  Am J Intellect Dev Disabil       Date:  2016-01

8.  Altered expression of KIF17, a kinesin motor protein associated with NR2B trafficking, may mediate learning deficits in a Down syndrome mouse model.

Authors:  Robin Roberson; Laura Toso; Daniel Abebe; Catherine Y Spong
Journal:  Am J Obstet Gynecol       Date:  2008-03       Impact factor: 8.661

Review 9.  Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome.

Authors:  Maria D Torres; Octavio Garcia; Cindy Tang; Jorge Busciglio
Journal:  Free Radic Biol Med       Date:  2017-09-28       Impact factor: 7.376

Review 10.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.